Medical World News

[Preciouslife1]

The EMA is NOTproviding a warm vote of confidence in the efficacy of JNJ or ASTRA ZENECAif they just let everything slide with just yellow flashing warning on their labels.

The European Medicines Agency (EMA) said on Tuesday its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine's labels, just as it has also required of rival vaccine maker AstraZeneca (AZN.L).
The review of the cases prompted a pause in the rollout of the vaccine in Europe and the United States last week, the latest blow to efforts to tackle the pandemic, which has killed more than 3.1 million and infected 142.1 million worldwide.
Several nations have suspended or limited the use of AstraZeneca's vaccine over possible blood clots. (https://bit.ly/3xckNFu)
The EMA examined eight cases of clotting that occurred in U.S. adults under 60 years, mostly women, within three weeks of vaccination with J&J's single shot